glp-1 availability Indications for GLP-1/GIP RA Summary Sheet and Beyond! GLP-1 receptor agonists causing euglycemic
Description
Stensen S, Gasbjerg LS, Helsted MM, Hartmann B, Christensen MB, Knop FK
Aurora, CO 80045, USA Wesley Nuffer, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA
Exogenous glucosedependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes
Trends Immunol 2018;39:489502
If companies pay for GLP-1s, do they see the return through lower healthcare costs and higher productivity
Sahoo, S., Kariya, T
